XORTX Therapeutics Inc. (XRTX) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About XORTX Therapeutics Inc.
XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat hyperuricemia related diseases in Canada. It develops XRx-026, which is in Phase III for the treatment of gout; XRx-008, which is in Phase II for the…
Source: Yahoo Finance
Sector & Industry
XORTX Therapeutics Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
XORTX Therapeutics Inc. at a Glance
| Company | XORTX Therapeutics Inc. |
| Ticker | XRTX |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $2.31 |
| Market cap | $4.20M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$2.58 |
| 52-week high | $7.05 |
| 52-week low | $1.73 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.44 |
| Return on equity (ROE) | -99.24% |
| Debt-to-equity | — |
| Average volume | 13,131 |
| Shares outstanding | 1.82M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | — |
| Country | Canada |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is XORTX Therapeutics Inc.'s current P/E ratio?
- XORTX Therapeutics Inc. (XRTX) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is XORTX Therapeutics Inc.'s market capitalisation?
- XORTX Therapeutics Inc.'s market cap is $4.20M based on our latest snapshot. See how it ranks by market cap →
- What is XRTX's 52-week range?
- Over the past 52 weeks, XRTX has traded between $1.73 and $7.05. What does the 52-week range mean? →
- How volatile is XORTX Therapeutics Inc. compared to the market?
- XORTX Therapeutics Inc. has a beta of 0.44, meaning it has historically moved less than the broader market. What does beta measure? →
- Does XORTX Therapeutics Inc. pay a dividend?
- XORTX Therapeutics Inc. does not currently pay a dividend according to our latest data.
- What exchange is XRTX listed on?
- XRTX is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is XORTX Therapeutics Inc. in?
- XORTX Therapeutics Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Philip Fisher on what makes a business worth owning for the long term.
Check Price →